Mark Eisner

Mark Eisner

Direttore Tecnico/Scientifico/R&S presso VIR BIOTECHNOLOGY, INC.

Patrimonio netto: 142 646 $ in data 30/06/2024

58 anni
Consumer Services
Health Technology
Miscellaneous

Provenienza dei contatti di primo grado di Mark Eisner

EntitàTipo di entitàSettore Industriale
Public Company Biotechnology 22
Public Company Pharmaceuticals: Major 13
The Genentech Foundation
1
Foundation/Endowment Investment Trusts/Mutual Funds 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Mark Eisner tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
ALZA CORPORATION Pharmaceuticals: Major

Kin Hung Yu

Chief Tech/Sci/R&D Officer

AMGEN INC. Pharmaceuticals: Major

Michael Martinelli

Aine M. Hanly

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Charles Sigal

Vicki Sato

Jeffrey Hatfield

Percy Carter

Chief Tech/Sci/R&D Officer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

JOHNSON & JOHNSON Pharmaceuticals: Major

Kin Hung Yu

Marianne de Backer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

BIOGEN INC. Pharmaceuticals: Major

Robert Perez

Phillip Sharp

Vicki Sato

George Scangos

Corporate Officer/Principal

Founder

Chief Tech/Sci/R&D Officer

Chief Executive Officer

SANGAMO THERAPEUTICS, INC. Biotechnology

Sona Saira Ramasastry

Sung Lee

Director/Board Member

Director of Finance/CFO

CASSAVA SCIENCES, INC. Biotechnology

Kin Hung Yu

Sona Saira Ramasastry

Corporate Officer/Principal

Director/Board Member

Investment Managers

Robert Nelsen

Vicki Sato

George Scangos

Founder

Private Equity Analyst

Private Equity Investor

AMBIT BIOSCIENCES CORP Pharmaceuticals: Major

Jeffrey Hatfield

Director/Board Member

ATYR PHARMA, INC. Pharmaceuticals: Major

Jeffrey Hatfield

Director/Board Member

Miscellaneous Commercial Services

Robert More

Jeffrey Hatfield

Director/Board Member

Director/Board Member

Biotechnology

Jeffrey Hatfield

Director/Board Member

College/University

Richard A. Farley

Enrique Conterno

Masters Business Admin

Masters Business Admin

College/University

Vicki Sato

Jeff Calcagno

Percy Carter

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Stanford University College/University

Edward D. Harris

Sona Saira Ramasastry

Corporate Officer/Principal

Graduate Degree

Miscellaneous Commercial Services

Jeffrey Hatfield

Corporate Officer/Principal

Miscellaneous Commercial Services

Kalevi Kurkijärvi

Chairman

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Charles Sigal

Phillip Sharp

Vicki Sato

Director/Board Member

Founder

Director/Board Member

Massachusetts Institute of Technology College/University

Phillip Sharp

Percy Carter

Corporate Officer/Principal

Masters Business Admin

Middlebury College College/University

Rory Riggs

Robert More

Undergraduate Degree

Undergraduate Degree

Purdue University College/University

Charles Sigal

Jeffrey Hatfield

Doctorate Degree

Undergraduate Degree

VITAE PHARMACEUTICALS INC Pharmaceuticals: Major

Jeffrey Hatfield

Chief Executive Officer

Medical Specialties

Kalevi Kurkijärvi

Chief Executive Officer

Miscellaneous Commercial Services

Phillip Sharp

Antonio Lanzavecchia

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Phillip Sharp

Janet Napolitano

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Charles Sigal

Phillip Sharp

Corporate Officer/Principal

Corporate Officer/Principal

Biomedical Sciences Careers Program, Inc.

Robert Perez

George Scangos

Director/Board Member

Director/Board Member

UC Davis School of Medicine College/University

George Scangos

Kin Hung Yu

Corporate Officer/Principal

Doctorate Degree

Bristol Myers International Group

Jeffrey Hatfield

President

Biotechnology

Phillip Sharp

Vicki Sato

Director/Board Member

Corporate Officer/Principal

The University of Cincinnati College of Medicine College/University

Lynne Krummen

Jennifer Towne

Doctorate Degree

Doctorate Degree

Harvard Medical School College/University

Jeff Calcagno

Doctorate Degree

INVIVO THERAPEUTICS HOLDINGS CORP. Biotechnology

Jeffrey Hatfield

Director/Board Member

Biotechnology

Kalevi Kurkijärvi

Chairman

Pharmaceuticals: Major

Jeffrey Hatfield

President

University of California College/University

George Scangos

Janet Napolitano

Corporate Officer/Principal

President

SYROS PHARMACEUTICALS, INC. Biotechnology

Phillip Sharp

Robert Nelsen

Vicki Sato

Director/Board Member

Director/Board Member

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Jeffrey Hatfield

Masters Business Admin

SPARK THERAPEUTICS, INC. Biotechnology

Charles Sigal

Robert Perez

Director/Board Member

Director/Board Member

DENALI THERAPEUTICS INC. Biotechnology

Robert Nelsen

Vicki Sato

Director/Board Member

Chairman

SIENNA BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Robert More

Robert Nelsen

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Jeffrey Hatfield

Marianne de Backer

Chairman

Director/Board Member

VIRIDIAN THERAPEUTICS, INC. Pharmaceuticals: Major

Jeffrey Hatfield

Chairman

Bio Orbit Oy

Kalevi Kurkijärvi

Chairman

AKOUOS Biotechnology

Vicki Sato

Sona Saira Ramasastry

Director/Board Member

Director/Board Member

Pharmaceuticals: Generic

Kin Hung Yu

Sona Saira Ramasastry

Chief Tech/Sci/R&D Officer

Director/Board Member

LARIMAR THERAPEUTICS, INC. Biotechnology

Jeffrey Hatfield

Chief Executive Officer

Statistiche

Distribuzione geografica

Stati Uniti 44
Finlandia 5
Canada 3
Svezia 2

Settori

Health Technology 28
Consumer Services 11
Commercial Services 9
Finance 3

Posizioni

Director/Board Member 258
Corporate Officer/Principal 83
Independent Dir/Board Member 74
Chairman 38
Chief Executive Officer 32